Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches.

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

Cencora has a solid industry position in an oligopolistic market with supernormal return ratios and solid stock price returns. 1QFY25 results, as well as the near-term outlook, are also solid ...

CONSHOHOCKEN, Pa. (AP) — CONSHOHOCKEN, Pa. (AP) — Cencora, Inc. (COR) on Wednesday reported fiscal first-quarter net income of $488.6 million. The Conshohocken, Pennsylvania-based company said ...

Long term Cencora, Inc. (NYSE:COR ... how EPS has changed over time (discover the exact values by clicking on the image). NYSE:COR Earnings Per Share Growth February 17th 2025 We like that ...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be obvious ...

Cencora, Inc. COR is well-poised for growth ... The company has a market capitalization of $44.82 billion. Image Source: Zacks Investment Research COR’s bottom line is anticipated to improve ...

Cencora, Inc. COR is well-poised for growth ... The company has a market capitalization of $49.31 billion. Image Source: Zacks Investment Research COR’s bottom line is anticipated to improve ...